Benign Prostatic Hyperplasia (BPH): Clinical Trials

61 trials for Benign Prostatic Hyperplasia (BPH), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33 completed, 8 recruiting, 7 not yet recruiting, 5 unknown. 28 Not applicable, 8 Phase 2, 7 Phase 4, 5 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable28Completed 10, Recruiting 6, Unknown 5, Not yet recruiting 2, Withdrawn 2, Active not recruiting 1, Enrolling by invitation 1, Terminated 1
Phase 28Completed 5, Terminated 2, Recruiting 1
Phase 47Completed 6, Not yet recruiting 1
Phase 35Completed 5
Phase 12Completed 2

Follow Benign Prostatic Hyperplasia (BPH): new trials by email Literature Review of Benign Prostatic Hyperplasia (BPH) trials Research Report on Benign Prostatic Hyperplasia (BPH)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The FLOW Registry.
Benign Prostatic Hyperplasia (BPH)
Not yet recruitingUniversity of Chicago30002026-11-012026-10-21
To Establish the Safety and Effectiveness of the ALPFA GRAIL PFA System for Treating Symptomatic Benign Prostate Hyperplasia (BPH) Also Known as an Enlarged Prostate.
Treatment Device: The ALPFA Medical (ALPFA) GRAIL™ Pulsed Field Ablation (PFA) System, Control Device: Sham flexible cystoscopy - Benign Prostatic Hyperplasia (BPH)
Not applicableRecruitingALPFA Medical2502026-10-012026-10-20
Prospective Post Market Clinical Trial for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH.
Zenflow Arm: Zenflow Spring System implant procedure, Medical Therapy Tamsulosin - Benign Prostatic Hyperplasia (BPH), Obstructive Lower Urinary Tract Symptoms (LUTS)
Phase 4Not yet recruitingZenflow, Inc.1102026-09-012026-09-01
STEAM-MAP 1 Study - Steam Therapy With MRI and AI-assisted Planning
MRI-TRUS fusion-guided Rezūm therapy - Benign Prostatic Hyperplasia (BPH)
Not applicableNot yet recruitingChinese University of Hong Kong152026-06-012026-06-23
Minimally Invasive Prostate Interventions Registry (MIST Study)
No intervention - Benign Prostatic Hyperplasia (BPH), Minimal Invasive Surgery
Not yet recruitingNecmettin Erbakan University20002026-03-252026-03-31
Inverted-T Incision With Early Apical Release vs. Three-Lobe in Holmium Laser Enucleation of The Prostate
inverted-T with early apical release technique, standard three-lobe technique - Prostate, Benign Prostatic Hyperplasia (BPH)
Not applicableEnrolling by invitationBenha University1402026-03-202026-06-11
TURP Outcome Prediction Calculator Study
Benign Prostatic Hyperplasia (BPH)
Not yet recruitingGeneral Hospital Sveti Duh2002026-03-022025-12-19
Laser Ablation a Salvage Treatment for Obstructive Benign Prostatic Hyperplasia
Transperineal Laser Ablation (TPLA) - Benign Prostatic Hyperplasia (BPH)
RecruitingThe Cleveland Clinic202026-01-122026-10-13
A Prospective Comparative Study Evaluating the Safety and Efficacy of Transurethral Thulium Fiber Laser, Holmium Laser and Bipolar Enucleation of Large Sized Prostate
Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP), Holmium Laser Enucleation of the Prostate (HoLEP), Bipolar Transurethral Enucleation of the Prostate (B-TUEP) - Benign Prostatic Hyperplasia (BPH), Lower Urinary Tract Symptom
Not applicableRecruitingTanta University902025-10-212026-06-05
Uroflowmetry Curve Types and IPSS in Men With LUTS
Lower Urinary Tract Symptoms (LUTS), Benign Prostatic Hyperplasia (BPH)
Not yet recruitingTarik Emre Sener2502025-09-152025-09-03
Evaluation of the Optilume BPH Catheter System and the Rezum Water Vapor Therapy in Treating Benign Prostatic Hyperplasia
Optilume® BPH Catheter System, Rezum Water Vapor Therapy - Benign Prostatic Hyperplasia (BPH), Lower Urinary Track Symptoms
Not applicableRecruitingCentre hospitalier de l'Université de Montréal (CHUM)1002025-05-092025-07-17
Clinical Study on Prostate Thermal Vapor Ablation Guided by MRI/TRUS Fusion Imaging
Transurethral Thermal Vaporization of the Prostate, Rezūm Water Vapor Thermal Therapy System - Benign Prostatic Hyperplasia (BPH)
Not applicableRecruitingChinese PLA General Hospital302025-04-152026-08-11
Desflurane Potentially Induces Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Perioperative Procedures by Modulating Cdc42 and Clock Proteins
Desflurane Inhalation, mechanical ventilation (MV) - Avascular Necrosis of the Femoral Head, Coronary Artery Disease (CAD)
Not applicableNot yet recruitingXiaguang Duan602025-02-012025-01-14
Effects of TNF Blockade on Human BPH/LUTS
Adalimumab - Benign Prostatic Hyperplasia (BPH)
Phase 2RecruitingEndeavor Health702024-01-242024-11-21
The Evaluation of Banana Flower Stamens Extract on Prevention of Benign Prostatic Hyperplasia in Adults
Placebo, Banana flower stamens extract - Benign Prostatic Hyperplasia (BPH)
Not applicableCompletedTCI Co., Ltd.502023-03-012026-05-29
To Linguistically and Psychometrically Validate the Hong Kong Chinese Version of the BPH 3-item Questionnaire
BPH 3-item questionnaire - Benign Prostatic Hyperplasia (BPH)
CompletedChinese University of Hong Kong662023-02-272026-10-22
Post-Market Study to Assess iTind Safety in Comparison to UroLift
iTind, UroLift - Benign Prostatic Hyperplasia (BPH)
Not applicableRecruitingOlympus Corporation of the Americas2562022-09-262026-09-29
REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men
REZŪM, alpha blocker and 5-alpha reductase inhibitor - Benign Prostatic Hyperplasia (BPH)
Not applicableActive not recruitingBoston Scientific Corporation1552021-09-152026-10-13
HoLEP in Management of BPH Patients With Predominant Voiding vs Storage LUTS: A Comparative Retrospective Study
Holmium Laser Enucleation of Prostate - Benign Prostatic Hyperplasia (BPH)
CompletedAssiut University1322021-08-012022-12-20
To Evaluate the Feasibility, Preliminary Safety and Performance of Rezūm System in BPH Treatment in China
Rezūm System - Benign Prostatic Hyperplasia (BPH)
CompletedBoston Scientific Corporation222021-07-102022-03-02

Showing 20 of 61. Sign in to see all of them.

Narrower conditions

Prostatic Hyperplasia (61)  ·  Lower Urinary Tract Symptoms (16)  ·  Urinary Bladder, Overactive (3)  ·  Coronary Artery Disease (2)  ·  Cholecystitis (1)  ·  Femur Head Necrosis (1)  ·  Genital Diseases, Male (1)  ·  Hyperplasia (1)  ·  Lymphoma, Follicular (1)  ·  Male Urogenital Diseases (1)  ·  Osteoarthritis, Knee (1)  ·  Prostatic Neoplasms (1)  ·  Prostatism (1)  ·  Urinary Bladder Neck Obstruction (1)  ·  Urinary Retention (1)

Broader conditions

Genital Diseases (61)  ·  Prostatic Diseases (61)  ·  Urogenital Diseases (61)  ·  Genital Diseases, Male (60)  ·  Male Urogenital Diseases (60)  ·  Pathological Conditions, Signs and Symptoms (19)  ·  Signs and Symptoms (18)  ·  Urological Manifestations (18)  ·  Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Urologic Diseases (5)  ·  Urinary Bladder Diseases (4)  ·  Arterial Occlusive Diseases (2)  ·  Arteriosclerosis (2)  ·  Cardiovascular Diseases (2)

Interventions

Tamsulosin (5)  ·  Aquablation (3)  ·  Finasteride (3)  ·  Saline Solution (2)  ·  Transurethral Resection of Prostate (2)  ·  fexapotide (2)  ·  saw palmetto extract (2)  ·  silodosin (2)  ·  5-alpha Reductase Inhibitors (1)  ·  Acupuncture Therapy (1)  ·  Adalimumab (1)  ·  Adrenergic alpha-Antagonists (1)  ·  Botulinum Toxins, Type A (1)  ·  Drug Delivery Systems (1)  ·  Electroacupuncture (1)

Sponsors

Boston Scientific Corporation (3)  ·  PROCEPT BioRobotics (3)  ·  Chinese University of Hong Kong (2)  ·  GemVax & Kael (2)  ·  HistoSonics, Inc. (2)  ·  Medi-Tate Ltd. (2)  ·  Northwestern University (2)  ·  Nymox Corporation (2)  ·  Pierre Fabre Medicament (2)  ·  ALPFA Medical (1)  ·  Assiut University (1)  ·  Astellas Pharma Taiwan, Inc. (1)  ·  Benha University (1)  ·  Boryung Pharmaceutical Co., Ltd (1)  ·  Brooklyn Urology Research Group (1)

Countries

United States (20)  ·  Italy (6)  ·  China (5)  ·  France (5)  ·  South Korea (5)  ·  Spain (4)  ·  Australia (3)  ·  Canada (3)  ·  Egypt (3)  ·  Switzerland (3)  ·  Taiwan (3)  ·  United Kingdom (3)  ·  Belgium (2)  ·  Germany (2)  ·  Hong Kong (2)

Top investigators

Kyung Seop Lee (2)  ·  Adelina Hrkac, MD (1)  ·  Ahsun Riaz, MD (1)  ·  Alexander P Glaser, M.D. (1)  ·  An-Hye Kim (1)  ·  Andrey Z Vinarov, PhD (1)  ·  Aurelien Descazeaud, MD (1)  ·  Ayman Mahdy, MD (1)  ·  Bartley Thornburg, MD (1)  ·  Bilal Chughtai, MD (1)  ·  Chadwick Huckabay, MD (1)  ·  Chi Fai NG, MD (1)  ·  Claude Schulman, MD (1)  ·  Claus Roehrborn, M.D. (1)

Results publications

PMID 29873008, PMID 12893330, PMID 19371887, PMID 21135869, PMID 21943105, PMID 22297243, PMID 23234617, PMID 23346990, PMID 23593139, PMID 26299520, PMID 26339465, PMID 26614889, PMID 27146488, PMID 28801563, PMID 30036614, PMID 30677455, PMID 30721737, PMID 31148056, PMID 31221864, PMID 32868137, PMID 33403529, PMID 33872051, PMID 33941632, PMID 34254333, PMID 34532768, PMID 36902647, PMID 37706750

NIH funding

2014 (1), 2025 (1), R01DK135516 (1)